• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health . A retrospective study of the clinical diagnosis and treatment of 158 cases of COVID-19

tetano

Editor, Senior Moderator
Front Public Health


. 2026 Jan 8:13:1622703.
doi: 10.3389/fpubh.2025.1622703. eCollection 2025.
A retrospective study of the clinical diagnosis and treatment of 158 cases of COVID-19

Xiangqi Chen[SUP] #[/SUP][SUP] 1 [/SUP], Suyun Zhang[SUP] #[/SUP][SUP] 2 [/SUP], Qunying Lin[SUP] 3 [/SUP], Xibin Zhuang[SUP] 4 [/SUP], Xiangyang Yao[SUP] 5 [/SUP], Li Lin[SUP] 6 [/SUP], Xiaoyun Chen[SUP] 1 [/SUP], Guoxiang Lai[SUP] 7 [/SUP], Baosong Xie[SUP] 8 9 [/SUP]


Affiliations
Abstract

Objective: This study aimed to summarize the clinical characteristics, management, and outcomes, and to identify independent risk factors associated with the severity in a cohort of coronavirus disease 2019 (COVID-19) patients from early-pandemic Fujian Province, China.
Methods: A total of 158 patients with confirmed COVID-19 were recruited from 10 designed hospitals of the Fujian province between January 22 and February 26, 2020. Their clinical, laboratory, computed tomography imaging, treatment, and outcome data were collected and summarized from electronic medical records. Potential independent risk factors associated with COVID-19 severity were explored by binary logistic multivariate regression.
Results: Of the 158 COVID-19 patients, 36 had mild, 106 had moderate, 8 had severe, and 8 had critical disease severity. The median age was 45 years (interquartile range 35-55) and 81 (51.3%) were men. 8.2% had a history of smoking. 31.6% had chronic underlying conditions, among which hypertension (13.9%), diabetes (7.6%), and liver disease (7.0%) were the most common. The most common initial symptom was fever, followed by cough, sputum expectoration, and muscle soreness. 94.3% of patients had abnormal imaging findings on chest computed tomography or X-ray. Patients with severe/critical disease had significantly more prominent laboratory abnormalities, including an abnormal lymphocyte count and abnormal levels of white blood cells, albumin, aspartate aminotransferase, creatine kinase, lactate dehydrogenase, and D-dimer than mild/moderate patients (all p < 0.05). Independent risk factors associated with severe/critical disease included age ≥ 60 years [Odds ratio (OR) = 19.9], WBC ≥ 10 × 10[SUP]9[/SUP]/L (OR = 47.5) and D-dimer > 0.5 mg/L (OR = 5.0) (p < 0.05). All patients received antiviral drugs; 126 (79.7%) also received traditional Chinese medicine and 29 (18.4%) received glucocorticoids. As of April 2, 133 patients (84.2%) were cured and discharged, 1 individual died (overall mortality, 0.6%), and the remaining 24 (15.2%) remained hospitalized after data gathering was completed.
Conclusion: COVID-19 patients from Fujian province during early pandemic presented mostly as mild/moderate cases with fever and cough as the initial symptoms. The detection of cellular immune function, coagulation function, myocardial damage, and liver function can help assess the severity of COVID-19. Specifically, the most important risk factors were older age, WBC elevation, and D-dimer elevation. Timely comprehensive treatment might be beneficial in controlling COVID-19.

Keywords: COVID-19; Fujian province; clinical characteristics; risk factors; severity; treatment.

 
Back
Top